Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Dodel

Showing results (151-160 of 250) with videos related to

Pageof 25
Sort By:
Biological Psychiatry|April 12, 2005
Decreased serum amyloid beta(1-42) autoantibody levels in Alzheimer's disease, determined by a newly developed immuno-precipitation assay with radiolabeled amyloid beta(1-42) peptideSylvia Brettschneider, Nils G Morgenthaler, Stefan J Teipel, et al.
Neuroscience and Biobehavioral Reviews|December 10, 2015
Health-Related Quality of Life in patients with Parkinson's disease--A systematic review based on the ICF modelJanet M T van Uem, Johan Marinus, Colleen Canning, et al.
BMC Geriatrics|August 16, 2019
Health outcome of older hospitalized patients in internal medicine environments evaluated by Identification of Seniors at Risk (ISAR) screening and geriatric assessmentAnne-Carina Scharf, Janine Gronewold, Christian Dahlmann, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 11, 2016
Cost-effectiveness of neurostimulation in Parkinson's disease with early motor complicationsJudith Dams, Monika Balzer-Geldsetzer, Uwe Siebert, et al.
Parkinsonism & Related Disorders|June 12, 2010
Affective and cognitive Theory of Mind in patients with parkinson's diseaseMaren E Bodden, Brit Mollenhauer, Claudia Trenkwalder, et al.
International Psychogeriatrics|August 27, 2015
Identifying factors of activities of daily living important for cost and caregiver outcomes in Alzheimer's diseaseCatherine Reed, Mark Belger, Bruno Vellas, et al.
Journal of Religion and Health|December 4, 2023
Meaning in Life in Late-Stage Parkinson's Disease: Results from the Care of Late-Stage Parkinsonism Study (CLaSP) in Six European CountriesSarah K Bublitz, Cornelia Brandstötter, Martin Fegg, et al.
Obesity Facts|September 17, 2011
Evaluation of the obesity genes FTO and MC4R and the type 2 diabetes mellitus gene TCF7L2 for contribution to stroke risk: The Mannheim-Heidelberg Stroke StudyYaroslav Winter, Tobias Back, André Scherag, et al.
Neuropsychiatrie : Klinik, Diagnostik, Therapie Und Rehabilitation : Organ Der Gesellschaft Osterreichischer Nervenarzte Und Psychiater|October 2, 2008
[Therapy of Alzheimer's disease: current status and future development]Reinhold Schmidt, Frauke Neff, Christian Lampl, et al.
Progress in Neurobiology|December 6, 2011
The future of Alzheimer's disease: the next 10 yearsHarald Hampel, David Prvulovic, Stefan Teipel, et al.
Pageof 25

Showing results (151-160 of 250) with videos related to

Sort By:
Pageof 25
Biological Psychiatry|April 12, 2005
Decreased serum amyloid beta(1-42) autoantibody levels in Alzheimer's disease, determined by a newly developed immuno-precipitation assay with radiolabeled amyloid beta(1-42) peptideSylvia Brettschneider, Nils G Morgenthaler, Stefan J Teipel, et al.
Neuroscience and Biobehavioral Reviews|December 10, 2015
Health-Related Quality of Life in patients with Parkinson's disease--A systematic review based on the ICF modelJanet M T van Uem, Johan Marinus, Colleen Canning, et al.
BMC Geriatrics|August 16, 2019
Health outcome of older hospitalized patients in internal medicine environments evaluated by Identification of Seniors at Risk (ISAR) screening and geriatric assessmentAnne-Carina Scharf, Janine Gronewold, Christian Dahlmann, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 11, 2016
Cost-effectiveness of neurostimulation in Parkinson's disease with early motor complicationsJudith Dams, Monika Balzer-Geldsetzer, Uwe Siebert, et al.
Parkinsonism & Related Disorders|June 12, 2010
Affective and cognitive Theory of Mind in patients with parkinson's diseaseMaren E Bodden, Brit Mollenhauer, Claudia Trenkwalder, et al.
International Psychogeriatrics|August 27, 2015
Identifying factors of activities of daily living important for cost and caregiver outcomes in Alzheimer's diseaseCatherine Reed, Mark Belger, Bruno Vellas, et al.
Journal of Religion and Health|December 4, 2023
Meaning in Life in Late-Stage Parkinson's Disease: Results from the Care of Late-Stage Parkinsonism Study (CLaSP) in Six European CountriesSarah K Bublitz, Cornelia Brandstötter, Martin Fegg, et al.
Obesity Facts|September 17, 2011
Evaluation of the obesity genes FTO and MC4R and the type 2 diabetes mellitus gene TCF7L2 for contribution to stroke risk: The Mannheim-Heidelberg Stroke StudyYaroslav Winter, Tobias Back, André Scherag, et al.
Neuropsychiatrie : Klinik, Diagnostik, Therapie Und Rehabilitation : Organ Der Gesellschaft Osterreichischer Nervenarzte Und Psychiater|October 2, 2008
[Therapy of Alzheimer's disease: current status and future development]Reinhold Schmidt, Frauke Neff, Christian Lampl, et al.
Progress in Neurobiology|December 6, 2011
The future of Alzheimer's disease: the next 10 yearsHarald Hampel, David Prvulovic, Stefan Teipel, et al.
Pageof 25